ESCALOX: Do selective radiation dose escalation and tumour hypoxia status impact the locoregional tumour control after radiochemotherapy of head neck tumours? Phase III study - A long run to begin - First patient in!

Pigorsch S. U.; Barta S.; Molls M.; Wilkens J.; Kampfer S.; Ganswindt U.; Combs S. E.

首页> 外文期刊>Strahlentherapie und Onkologie >ESCALOX: Do selective radiation dose escalation and tumour hypoxia status impact the locoregional tumour control after radiochemotherapy of head neck tumours? Phase III study - A long run to begin - First patient in!

【24h】

ESCALOX: Do selective radiation dose escalation and tumour hypoxia status impact the locoregional tumour control after radiochemotherapy of head neck tumours? Phase III study - A long run to begin - First patient in!

机译：Escalox：选择性辐射剂量升级和肿瘤缺氧地位会影响头颈肿瘤放射性化疗后的局部肿瘤对照吗？第三阶段研究 - 长期开始 - 首先患者！

获取原文

获取原文并翻译 | 示例

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《Strahlentherapie und Onkologie》 |2016年第1期|共1页
作者
Pigorsch S. U.; Barta S.; Molls M.; Wilkens J.; Kampfer S.; Ganswindt U.; Combs S. E.;
展开▼
作者单位

Helmholtz Zentrum Munchen Deutsch Forschungszentr Inst Innovat Radiotherapie iRT Munich Germany;

展开▼
收录信息
原文格式 PDF
正文语种 ger
中图分类放射医学;
关键词

相似文献

外文文献
中文文献
专利

1. ESCALOX: Do selective radiation dose escalation and tumour hypoxia status impact the locoregional tumour control after radiochemotherapy of head neck tumours? Phase III study - A long run to begin - First patient in! [J] . Pigorsch S. U., Barta S., Molls M., Strahlentherapie und Onkologie . 2016,第Suppla1期

机译：Escalox：选择性辐射剂量升级和肿瘤缺氧地位会影响头颈肿瘤放射性化疗后的局部肿瘤对照吗？第三阶段研究 - 长期开始 - 首先患者！
2. Determination of tumour hypoxia with ((18)F)EF3 in patients with head and neck tumours: a phase I study to assess the tracer pharmacokinetics, biodistribution and metabolism. [J] . Mahy P, Geets X, Lonneux M, European Journal of Nuclear Medicine and Molecular Imaging . 2008,第7期

机译：用（（18）F）EF3在头颈部肿瘤患者中确定肿瘤缺氧：I期研究，以评估示踪剂的药代动力学，生物分布和代谢。
3. Determination of tumour hypoxia with [18F]EF3 in patients with head and neck tumours: a phase I study to assess the tracer pharmacokinetics, biodistribution and metabolism [J] . P. Mahy, X. Geets, M. Lonneux, European Journal of Nuclear Medicine and Molecular Imaging . 2008,第7期

机译：[18 F] EF3在头颈部肿瘤患者中确定肿瘤缺氧的I期研究，以评估示踪剂的药代动力学，生物分布和代谢
4. Clinical management of tumour volume changes in VMAT head neck radiation treatment [C] . K M Alexander, J Gooding, L J Schreiner, International Conference on 3D Radiation Dosimetry . 2016

机译：VMAT头部辐射处理肿瘤体积变化的临床管理
5. Do selective radiation dose escalation and tumour hypoxia status impact the loco-regional tumour control after radio-chemotherapy of head neck tumours? The ESCALOX protocol [O] . Steffi U. Pigorsch, Jan J. Wilkens, Severin Kampfer, 2017

机译：头颈部肿瘤放化疗后选择性放射剂量的升高和肿瘤低氧状态是否会影响局部区域的肿瘤控制？ ESCALOX协议
6. Do selective radiation dose escalation and tumour hypoxia status impact the loco-regional tumour control after radio-chemotherapy of head neck tumours? The ESCALOX protocol [O] . Steffi U. Pigorsch, Jan J. Wilkens, Severin Kampfer, 2017

机译：头颈部肿瘤放化疗后，选择性放射剂量的升高和肿瘤低氧状态是否会影响局部区域的肿瘤控制？ ESCALOX协议

ESCALOX: Do selective radiation dose escalation and tumour hypoxia status impact the locoregional tumour control after radiochemotherapy of head neck tumours? Phase III study - A long run to begin - First patient in!

著录项

引文网络

相似文献

相关主题

期刊订阅